Reaction
Erosive Pustular Dermatosis reporting signals
As of the last recalculation, Erosive Pustular Dermatosis appears in 47 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is PEMETREXED (PRR 658.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pemetrexed | 19 | 658.0 | 658.6 |
| Pemetrexed Disodium | 20 | 403.9 | 404.1 |
| Erlotinib Hydrochloride | 7 | 290.9 | 291.1 |
| Erlotinib | 5 | 255.7 | 255.8 |